HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward Rosfjord Selected Research

auristatin

1/2022Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
10/2020PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers.
1/2018Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1).
11/2017A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward Rosfjord Research Topics

Disease

11Neoplasms (Cancer)
01/2022 - 01/2004
3Breast Neoplasms (Breast Cancer)
10/2020 - 06/2012
2Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2020
2Neoplasm Metastasis (Metastasis)
11/2017 - 06/2012
1Melanoma (Melanoma, Malignant)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Leukemia
01/2021
1Lung Neoplasms (Lung Cancer)
10/2020
1Colonic Neoplasms (Colon Cancer)
01/2020
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2020
1Triple Negative Breast Neoplasms
11/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017
1Ovarian Neoplasms (Ovarian Cancer)
11/2017
1Tics (Tic)
11/2017
1Prostatic Neoplasms (Prostate Cancer)
06/2012
1Aneuploidy (Aneuploid)
07/2010

Drug/Important Bio-Agent (IBA)

6Immunoconjugates (Immunoconjugate)IBA
01/2022 - 11/2017
4auristatinIBA
01/2022 - 11/2017
3Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2014
3Proteins (Proteins, Gene)FDA Link
12/2021 - 06/2012
3Pharmaceutical PreparationsIBA
10/2020 - 11/2017
2Enterotoxin ReceptorsIBA
12/2021 - 01/2020
2AntigensIBA
01/2021 - 01/2021
2Ado-Trastuzumab EmtansineIBA
10/2020 - 01/2018
1Extracellular Matrix ProteinsIBA
01/2022
1Histones (Histone)IBA
01/2022
1Fibronectins (Fibronectin)IBA
01/2022
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1Cysteine (L-Cysteine)FDA Link
10/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Monoclonal AntibodiesIBA
11/2017
1CitrullineIBA
11/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2017
1Valine (L-Valine)FDA Link
11/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2017
1Protein Kinases (Protein Kinase)IBA
06/2012
1Phosphatidylinositols (Phosphatidylinositol)IBA
06/2012
1GTP Phosphohydrolases (GTPases)IBA
06/2012
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
06/2012
1Antineoplastic Agents (Antineoplastics)IBA
07/2010
1Bovine Serum AlbuminIBA
01/2004
1Culture MediaIBA
01/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2004

Therapy/Procedure

4Therapeutics
01/2022 - 11/2017
1Immunotherapy
01/2020
1Aftercare (After-Treatment)
11/2017
1Drug Therapy (Chemotherapy)
11/2017
1Transplantation
11/2017